Brief: ReShape Lifesciences Reaffirms Commitment To Profitability

Vyome Holdings

04/03/2024 15:03

March 4 (Reuters) - ReShape Lifesciences Inc  RSLS.O :
    * RESHAPE LIFESCIENCES® PROVIDES UPDATE ON 2024 COST
REDUCTION
PLAN AND REORGANIZATION TO PRIORITIZE COMMERCIALIZATION OF
LAP-BAND® 2.0 FLEX
    * RESHAPE LIFESCIENCES INC: 2024 OPERATING EXPENSES EXPECTED
TO
DECREASE BY 55.4% COMPARED TO 2023
    * RESHAPE LIFESCIENCES INC: SIGNIFICANT COST REDUCTIONS
INCLUDING
A FURTHER REDUCTION IN STAFF
    * RESHAPE LIFESCIENCES INC - COMPANY REAFFIRMS COMMITMENT TO
PROFITABILITY
    * RESHAPE LIFESCIENCES INC - FULL IMPLEMENTATION OF PLAN IS
EXPECTED TO RESULT IN LOWER OPERATING EXPENSES OF APPROXIMATELY
$7.9 MILLION IN 2024

Source text for Eikon:  ID:nGNXPJWFH 
Further company coverage:  RSLS.O 

 ((Reuters.Briefs@thomsonreuters.com;))